Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia

American Journal on Addictions

Volumn 15, Issue 1, 2006, Pages 44-49

  Petrakis, Ismene L ^a,c   Leslie, Douglas ^a   Finney, John W ^b   Rosenheck, Robert ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c Substance Abuse Treatment Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ADULT; ALCOHOLISM; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG MISUSE; DRUG SUBSTITUTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; SAMPLE SIZE; SCHIZOPHRENIA; SCORING SYSTEM; STUDENT T TEST; SUBSTANCE ABUSE; VETERAN;

ADMINISTRATION, ORAL; ADULT; ALCOHOLISM; AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PERSONALITY ASSESSMENT; PSYCHOMETRICS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS; SUBSTANCE-RELATED DISORDERS; VETERANS;

EID: 32144463313     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490500419052     Document Type: Article

References (34)

1. Greenberg G, Rosenheck R. National Mental Health Program Performance Monitoring System: Fiscal Year 2002 Report. Northeast Program Evaluation Center, Veterans Affairs; 2003.
2. Rieger DA, Farmer ME, Rae DS. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiological Catchment Area (ECA) study. JAMA. 1990;264:2511-2518.
3. Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res. 1999;35:S93-S100.
4. Gerding LB, Labbate LA, Measom MO, et al. Alcohol dependence and hospitalization in schizophrenia. Schizophr Res. 1999;38:71-75.
5. Ziedonis D, Richardson T, Lee E, et al. Adjunctive desipramine in the treatment of cocaine abusing schizophrenics. Psychopharmacol Bull. 1992;28:309-314.
6. Petrakis IL, O'Malley S, Rounsaville B, et al. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia. Psychopharmacology. 2004;172:291-297.
7. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789-796.
8. Tollefson GD, Beasley CM Jr, Tran PV, et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry. 1997;154:457-465.
9. Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia: a high- and low-dose double-blind comparison with placebo, Seroquel study group. Arch Gen Psychiatry. 1997;54:549-557.
10. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry. 1994;151:825-835.
11. Markowitz JS, Brown CS, Moore TR. Atypical antipsychotics, part I: pharmacology, pharmacokinetics, and efficacy. Ann Pharmacother. 1999;33:73-85.
12. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry. 1985;142:1259-1264.
13. Krystal JH, D'Souza DC, Madonick S, et al. Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients. Schizophr Res. 1999;35(Suppl):S35-S49.
14. Wilkins J. Pharmacotherapy of schizophrenia patients with comorbid substance abuse. Schizophr Bull. 1997;23:215-228.
15. Buckley PF. Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia. J Subst Abuse Treat. 1998; 15:113-116.
16. Albanese MJ, Khantzian EJ, Murphy SL, et al. Decreased substance use in chronically psychotic patients treated with clozapine [letter]. Am J Psychiatry. 1994;151:780-781.
17. Yovell Y, Opler LA. Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: a case report and a hypothesis. J Nerv Ment Dis. 1994;182:591-592.
18. Marcus P, Snyder R. Reduction of comorbid substance abuse with clozapine. Am J Psychiatry. 1995;152:959.
19. Volavka J. The effects of clozapine on aggression and substance abuse in schizophrenic patients. J Clin Psychiatry. 1999;60:43-46.
20. Kosten TA, Nestler EJ. Clozapine attenuates cocaine-conditioned place preference. Life Sci. 1994;55:L9-L14.
21. Drake RE, Xie H, McHugo GJ, et al. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull. 2000;26:441-449.
22. Littrell K, Petty R, Hilligoss N, Peabody C, Johnson C. Olanzapine treatment for patients with schizophrenia and substance abuse. J Subst Abuse Treat. 2001;21:217-221.
23. McLellan A, Luborsky L, Woody G, et al. An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26-33.
24. Carroll KM, Nich C, Ball SA, et al. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction. 1998;93:713-727.
25. Anton RF, Moak DH, Waid R, et al. Naltrexone and cognitive behavioral therapy for treatment of outpatient alcoholics: result, a placebo-controlled trial. Am J Psychiatry. 1999;156:1758-1764.
26. Project Match Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol. 1997;58:7-29.
27. Crits-Christoph P, Siqueland L, Blaine JD, et al. Psychosocial treatments for cocaine dependence. Arch Gen Psychiatry. 1999;56:493-502.
28. Rosenheck R, Perlick D, Bingham SF, et al. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized and controlled trial. JAMA. 2003;290:2693-2702.
29. Kampman KM, Pettinati H, Lynch KG, et al. A pilot trial of olanzapine for the treatment of cocaine dependence. Drug Alcohol Depend. 2003;70:265-273.
30. Volpicelli JR, Alterman A, Hayashida M, et al. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876-880.
31. O'Malley SS, Jaffe AJ, Chang G, et al. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry. 1992;49:881-887.
32. Carroll KM. Manual-guided psychosocial treatment: a new virtual requirement for pharmacotherapy trials? [comment]. Arch Gen Psychiatry. 1997;54:923-928.
33. Mueser K, Noordsy D, Fox L, et al. Disulfiram treatment for alcoholism in severe mental illness. Am J Addict. 2003;12:242-252.
34. Shaner A, Roberts LJ, Eckman TA, et al. Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence. Psychiatr Serv. 1997;48:807-810.